Geode Capital Management’s Context Therapeutics CNTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Sell |
637,810
-1,409
| -0.2% | -$924 | ﹤0.01% | 3609 |
|
|
2025
Q1 | $391K | Buy |
639,219
+10,490
| +2% | +$6.42K | ﹤0.01% | 3637 |
|
|
2024
Q4 | $661K | Buy |
628,729
+52,830
| +9% | +$55.5K | ﹤0.01% | 3514 |
|
|
2024
Q3 | $1.13M | Sell |
575,899
-42,275
| -7% | -$82.9K | ﹤0.01% | 3312 |
|
|
2024
Q2 | $1.24M | Buy |
618,174
+517,102
| +512% | +$1.04M | ﹤0.01% | 3232 |
|
|
2024
Q1 | $140K | Buy |
101,072
+3,832
| +4% | +$5.29K | ﹤0.01% | 4047 |
|
|
2023
Q4 | $110K | Hold |
97,240
| – | – | ﹤0.01% | 4158 |
|
|
2023
Q3 | $147K | Sell |
97,240
-9,994
| -9% | -$15.1K | ﹤0.01% | 4103 |
|
|
2023
Q2 | $172K | Buy |
107,234
+47,666
| +80% | +$76.3K | ﹤0.01% | 4107 |
|
|
2023
Q1 | $33.5K | Sell |
59,568
-1,634
| -3% | -$919 | ﹤0.01% | 4607 |
|
|
2022
Q4 | $40K | Buy |
61,202
+2,530
| +4% | +$1.65K | ﹤0.01% | 4652 |
|
|
2022
Q3 | $65K | Hold |
58,672
| – | – | ﹤0.01% | 4704 |
|
|
2022
Q2 | $124K | Buy |
58,672
+8,760
| +18% | +$18.5K | ﹤0.01% | 4496 |
|
|
2022
Q1 | $108K | Buy |
+49,912
| New | +$108K | ﹤0.01% | 4634 |
|